TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

April 30, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

etanercept given by perispinal administration

Trial Locations (1)

90095

Edward Tobinick, MD (private medical office), Los Angeles

All Listed Sponsors
lead

Tobinick, Edward Lewis, M.D.

OTHER

NCT00203359 - TNF-Alpha Inhibition for Treatment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter